A Win For Plus Therapeutics, Inc.

Plus Therapeutics, Inc. (PSTV:NASDAQ) rocketted at $0.56, representing a gain of 39.3%. On Thu, Sep 25, 2025, PSTV:NASDAQ touched a New 2-Week High of $0.56. The stock got featured on our News Catalysts scanner on Thu, Sep 25, 2025 at 10:47 AM in the 'AGREEMENT' category. From Thu, Sep 11, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Tue, Aug 05, 2025 at $0.9 with a volume of 47M+.

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.